Exam (elaborations)
NAPSRX CNPR EXAM (REVISED 18TH EDITION) QUESTIONS AND ANSWERS WITH SOLUTIONS 2024
NAPSRX CNPR EXAM (REVISED 18TH EDITION) QUESTIONS AND ANSWERS WITH SOLUTIONS 2024
[Show more]
Uploaded on
September 15, 2024
Number of pages
5
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
Napsrx
Course
Napsrx
$13.49
Also available in package deal from $96.24
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
$ 238.13
$ 96.24
17 items
1. Exam (elaborations) - Napsrx exam questions and answers with solutions 2024
2. Exam (elaborations) - Napsrx cnpr exam (revised 18th edition) questions and answers with solutions 2024
3. Exam (elaborations) - Napsr/cnpr exam questions and answers with solutions 2024
4. Exam (elaborations) - Napsr exam (practice quizzes) and answers with solutions 2024
5. Exam (elaborations) - Napsrx study guide questions and answers with solutions 2024
6. Exam (elaborations) - Napsrx final exam question and answers with solutions 2024
7. Exam (elaborations) - Cnpr exam word doc questions and answers with solutions 2024
8. Exam (elaborations) - Napsr quiz 16 questions and answers with solutions 2024
9. Exam (elaborations) - Napsr quiz 14 questions and answers with solutions 2024
10. Exam (elaborations) - Napsr certification questions and answers with solutions 2024
11. Exam (elaborations) - Napsrx chapter 8 questions and answers with solutions 2024
12. Exam (elaborations) - Napsr 16th edition review questions and answers with solutions 2024
13. Exam (elaborations) - Napsr 1-3 questions and answers with solutions 2024
14. Exam (elaborations) - Napsr cnpr chapter 12 biopharmaceutical drug development questions and answers with s...
15. Exam (elaborations) - Napsrx ch. 21 terminology questions and answers with solutions 2024
16. Exam (elaborations) - Napsrx chapter 11 (clinical trial) questions and answers with solutions 2024
17. Exam (elaborations) - Chapter 5 & 6 questions and answers with solutions 2024
Show more
NAPSRX CNPR EXAM (REVISED 18TH
EDITION) QUESTIONS AND ANSWERS
WITH SOLUTIONS 2024
whatKdoesKaKSTATKorderKmean?K-KANSWERKaKdrugKneededKimmediatelyKandKgivenKonlyKonce
whatKinformationKdoesKtheKoverdosageKsectionKofKtheKlabelingKprovide?K-
KANSWERKsigns,KsymptomsKandKtreatmentKofKacuteKoverdoses
typesKofKdrug-drugKinteractions:K-KANSWERKduplication,KoppositionK(antagonism)KandKalterationK(p.51)
toleranceKvsKresistanceK-
KANSWERKtoleranceKisKtheKdiminishedKresponseKtoKaKdrug;KresistanceKisKtheKcellsKabilityKtoKresistKtheKeffect
sKofKtheKdrugKonKthem.
abbreviatedKnewKdrugKapplicationK(ANDA)K-
KANSWERKtheKprocessKbyKwhichKapplicantsKmustKscientificallyKdemonstrateKtoKtheKFDAKthatKtheirKgenericKp
roductKisKbioequivalentKtoKorKperformsKinKtheKsameKwayKasKtheKinnovatorKdrug,KnoKduplicateKtestingK(p.K75
)
theKHatch-WaxmanKActKofK1984K-KANSWERK-A.K.A.KDrugKPriceKCompetitionKandKPatentKRestorationKAct
-
madeKitKeasierKtoKbringKgenericKdrugsKtoKtheKmarketKbyKrequiringKtheKFDAKtoKonlyKlookKatKbioavailabilityKst
udiesKinKorderKtoKapproveKanKANDA.
-gaveKprotectionKtoKtheKresearchKbasedKmanufacturersKbyKprovidingKaK30-
monthKautomaticKcoolingKoffKperiodKonceKanKANDAKisKchallengedKforKpatentKinfringementK(p.K75)
fourKbasicKtransportKmechanismsK-
KANSWERKpassiveKdiffusion,KfacilitatedKdiffusion,KactiveKtransport,KandKpinocytosisK(p.K95)
potencyKvsKefficacyK-KANSWERKpotency:KamountKofKdrugKnecessaryKtoKproduceKdesiredKeffect
efficacy:KmagnitudeKofKmaximalKresponseKthatKcanKbeKreceivedKfromKaKdrug
*efficacyKisKalmostKalwaysKmoreKimportantKthatKpotency*K(p.K106)
, theKfourKphasesKofKclinicalKtrialsK-KANSWERKphasesKI-IVK(P.K124-126)
KeyKPartsKOfKAKClinicalKPaperK(5)K-
KANSWERKAbstract,KIntroduction,Kmethods,Kresults,Kdiscussion/conclusionsK(p.K128-129)
reliabilityKvsKvalidityK-KANSWERKreliabilityK=KconsistencyKandKvalidityK=Kaccuracy
(p.K138;K143)
samplingKerrorKvsKselectionKbiasK-
KANSWERKsamplingKerrorKisKunbiasedKandKisKrandomlyKchosenKfromKtheKpopulation.K
selectionKbiasKisKwhenKtheKsampleKwasKspecificallyKchosenKbasedKonKparticularKcharacteristicsK(p.142-143)
independentKvsKdependentKvariableK-
KANSWERKAnKindependentKvariableKisKtheKoneKthatKinfluencesKtheKvariation.KAKdependentKvariableKisKtheKv
ariableKbeingKtestedKandKmeasuredKinKaKscientificKexperimentK(theKresultKofKapplyingKtheKindependentKvari
able).
DrugKUtilizationKReviewK(DUR)KprogramsK-KANSWERK-
involveKretrospectiveKmonitoringKofKphysicians'KprescribingKpatterns
-moreKthanK90%KofKHMOsKrequireKDURs
-nowadaysKmostlyKmonitorsKcostKsavingsK(p.K181)
opportunityKcostK-
KANSWERKbasedKonKtheKpremiseKthatKallKresourcesKareKscarce,KandKthereforeKeveryKtimeKweKchooseKtoKuse
KaKresourceKitKreducesKtheKpossibilityKofKitKbeingKusedKinKanotherKway.
whatKtypeKofKDTCKadvertisingKisKtheKonlyKlegalKformKinKEurope?K-KANSWERKDisease-
stateKorKunbrandedKadsK(providesKpublicKinformationKonKaKdisease,KnotKaKdrug)
(p.K223)